Introduction
Materials and methods
Participants and data collection
Clinical diagnoses
Pathological diagnoses
1. IgA nephropathy
|
1) Primary IgA nephropathy |
2) Secondary IgA nephropathy |
(1) Hepatological disorder* |
(2) Others* |
2. Minimal change disease (MCD)
|
1) Primary (idiopathic) MCD |
2) Secondary MCD |
(1) Malignancy* |
(2) Drug-induced* |
(3) Others* |
3. Focal segmental glomerulosclerosis (FSGS)
|
1) Primary (idiopathic) FSGSa |
2) Secondary FSGS |
(1) Familial/genetic* |
(2) Obesity |
(3) Low birth weight* |
(4) Hypertension/arteriosclerosis* |
(5) Drug-induced* |
(6) Others* |
4. Membranous nephropathy
|
1) Primary (idiopathic) Membranous nephropathy |
2) Secondary Membranous nephropathy |
(1) Malignancy* |
(2) Drug-induced* |
(3) Infection*,b |
(4) Others* |
5. Membranoproliferative glomerulonephritis (MPGN)
|
1) Primary MPGNc |
(1) Type I MPGN |
(2) Type III MPGN* |
2) Secondary MPGNd |
(1) Secondary MPGN* |
(2) Others* |
6. C3 glomerulopathy
|
1) Dense deposit disease (DDD) |
2) C3 glomerulonephritis |
7. Vasculitis syndrome
e
|
1) ANCA-associated vasculitis |
(1) Microscopic polyangiitis (MPA) |
(2) Granulomatous polyangiitis (GPA) |
(3) Eosinophilic granulomatous polyangiitis (EGPA) |
(4) Drug-induced* |
(5) Unclassified* |
2) Anti-glomerular basement membrane (GBM) diseasef |
3) IgA vasculitis (Henoch-Schönlein purpura nephritis)g |
4) Polyarteritis nodosa |
5) Others*,h |
8. Nephropathy associated with connective tissue diseases
|
1) Lupus nephritisi |
2) Sjögren syndrome |
(1) Tubulointerstitial nephritis |
(2) Others* |
3) Rheumatoid arthritis*,j |
4) Systemic sclerosis |
(1) Thrombotic microangiopathy |
(2) Others* |
5) Others* |
9. Infection related glomerulonephritis
|
1) Poststreptococcal acute glomerulonephritis |
2) Staphylococcus associated glomerulonephritis* |
3) HBV-associated nephropathy |
(1) Membranous nephropathy |
(2) Others* |
4) HCV-associated nephropathy |
(1) MPGN |
(2) Others* |
5) Parvovirus related glomerulonehritis |
6) HIV associated nephropathy |
7) Others* |
10. Other glomerulonephropathies
|
1) IgM nephropathy |
2) C1q nephropathy |
3) Others* |
11. Hypertension/arteriosclerosis
|
1) Nephrosclerosis |
(1) Essential hypertension/arteriosclerosis |
(2) Malignant hypertension |
2) Choresterol crystal embolization |
3) Others*,k |
12. Thrombotic microangiopathy(TMA)・endothelial injury
|
1) Shiga toxin-production E coli hemolytic uremic syndrome (STEC-HUS) |
2) Atypical hemolytic uremic syndrome (aHUS) |
3) Preeclampsia |
4) Drug-induced* |
5) Others* l |
13. Diabetic nephropathy
|
1) Diabetic nephropathy |
14. Nephropathies with altered lipid metabolism
|
1) Lipoprotein glomerulopathy |
2) LCAT deficiency |
3) Others* |
15. Paraprotein-related kidney disesase
m
|
1) Monoclonal immunoglobulin deposit disease (MIDD) |
(1) Light chain deposition disease (LCDD) |
(2) Heavy chain deposition disease (HCDD) |
(3) Light and heavy chain deposition disease (LHCDD) |
2) Proliferative glomerulonephritis with monoclonal IgG deposits (PGNMID)n |
3) Cast nephropathy* |
4) Others* |
16. Cryoglobulinemic vasculitis
|
1) Cryoglobulinemic vasculitiso |
(1) Hematological/lymphoproliferative disorders* |
(2) Others/unknown etiology* |
17. Nephropathies with organized deposit
|
1) Immunotactoid glomerulopathy |
2) Fibrillary glomerulonephritis |
3) Fibronectin glomerulopathy |
4) Collagenofibrotic nephropathy |
5) Others* |
18. Renal amyloidosis
|
1) AA amyloidosis* |
2) AL amyloidosis* |
3) Other type of amyloidosis*,p |
19. Congenital/genetic
|
1) Congenital nephrotic syndromeq |
2) Alport syndrome |
3) Thin basement membrane disease |
4) Fabry disease |
5) Renal disease associated with mitochondrial cytopathy |
6) Autosomal dominant tubulointerstitial kidney disease (ADTKD): including medullary cystic kidney disease (MCKD) |
7) Nephronophthisis/nephronophthisis-associated ciliopathies |
8) Polycystic kidney disease |
(1) Autosomal dominant polycystic kidney disease (ADPKD) |
(2) Autosomal recessive polycystic kidney disease (ARPKD) |
(3) Others |
9) Congenital anomalies of the kidney and urinary tract (CAKUT) |
(1) Syndromic CAKUT |
(2) Non-syndromic CAKUT |
10) Nail-patella syndrome/LMX1B associated nephropathy |
11) Others* |
20. Tubulointerstitial nephropathies
|
1) Tubulointerstitial nephritis |
(1) Drug-induced* |
(2) IgG4-related kidney disease |
(3) Sarcoidosis |
(4) Tubulointerstitial nephritis and uveitis (TINU) syndrome |
(5) Others*,r |
(6) Unknown |
2) Acute tubular necrosis |
3) Others* |
21. Transplant kidney
|
1) Transplant rejection |
(1) Hyperacute rejection |
(2) Acute rejection |
① Acute antibody mediated rejection |
② Acute T-cell mediated rejection |
(3) Chronic rejection |
① Chronic antibody mediated rejection |
② Chronic T-cell mediated rejection |
(4) Others* |
2) Drug-induced graft injury |
(1) Calcineurin inhibitor induced nephropathy |
(2) Others* |
3) Transplant related infection |
(1) BK virus |
(2) Adenovirus |
(3) Epstein–Barr viruss |
(4) Cytomegalovirus |
(5) Others* |
4) Post-transplant lymphoproliferative disorders (PTLD) |
5) No specific findings |
6) Others* |
22. Others
|
1) No specific abnormalities |
2) Others* |
3) Undiagnosable* |